Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	qHPV Vaccine: Base Study
Total, all-cause mortality	Placebo: Base Study
Total, all-cause mortality	qHPV Vaccine: EXT1
Total, all-cause mortality	Long-term Follow-up: EXT2
Total, other adverse events	qHPV Vaccine: Base Study	1,565	1,890
Total, other adverse events	Placebo: Base Study	1,390	1,888
Total, other adverse events	qHPV Vaccine: EXT1	2	1,327
Total, other adverse events	Long-term Follow-up: EXT2	0	1,336
Total, serious adverse events	qHPV Vaccine: Base Study	15	1,890
Total, serious adverse events	Placebo: Base Study	17	1,888
Total, serious adverse events	qHPV Vaccine: EXT1	6	1,327
Total, serious adverse events	Long-term Follow-up: EXT2	6	1,336

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00090220/event-totals